Literature DB >> 10695078

The role of the endothelium in modulating vascular control in sepsis and related conditions.

S J Wort1, T W Evans.   

Abstract

The majority of deaths amongst critically ill patients requiring intensive care are attributable to sepsis and its sequelae: septic shock, the systemic inflammatory response syndrome (SIRS) and the acute respiratory distress syndrome (ARDS). Patients within the ICU who develop these conditions and fail to survive succumb to multiple organ dysfunction syndrome (MODS). ARDS is considered to be the pulmonary component of MODS and is characterized by pulmonary hypertension, often in the setting of systemic hypotension. Endothelial cells, normally responsible for modulating vascular tone, becomes dysfunctional in sepsis. Pro-thrombotic, pro-inflammatory and vasoactive mediators are released including nitric oxide (NO), endothelins (ETs) and products of cyclo-oxygenase metabolism. It is probably the disordered production of these mediators in vascular beds that results in MODS. This review highlights recent research in this area with particular emphasis on possible therapeutic options.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10695078     DOI: 10.1258/0007142991902286

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  20 in total

1.  Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-κB activation by disrupting lipid rafts in CD14-negative endothelial cells.

Authors:  Guoquan Meng; Yiyao Liu; Changchun Lou; Hong Yang
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells.

Authors:  Mouhamed Djahoum Moussa; Cristina Santonocito; David Fagnoul; Katia Donadello; Olivier Pradier; Pascale Gaussem; Daniel De Backer; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2014-12-16       Impact factor: 17.440

3.  Cutaneous venous dysfunction studied in vivo in the LPS-treated rabbit: implication of NO in saphenous vein hyporeactivity.

Authors:  Christine Vayssettes-Courchay; Marta Chataigneau; Cedric Protin; Christophe Ragonnet; Tony J Verbeuren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-02       Impact factor: 3.000

Review 4.  Pathophysiology of pulmonary hypertension in acute lung injury.

Authors:  Laura C Price; Danny F McAuley; Philip S Marino; Simon J Finney; Mark J Griffiths; Stephen John Wort
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-13       Impact factor: 5.464

5.  Time-dependent alterations of VEGF and its signaling molecules in acute lung injury in a rat model of sepsis.

Authors:  Subrina Jesmin; Sohel Zaedi; A M Shahidul Islam; S Nusrat Sultana; Yoshio Iwashima; Takeshi Wada; Naoto Yamaguchi; Michiaki Hiroe; Satoshi Gando
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 6.  Pulmonary endothelium in acute lung injury: from basic science to the critically ill.

Authors:  S E Orfanos; I Mavrommati; I Korovesi; C Roussos
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

7.  Investigation of novel LPS-induced differentially expressed long non-coding RNAs in endothelial cells.

Authors:  Krishna K Singh; Pratiek N Matkar; Shoaib Muhammad; Adrian Quan; Vijay Gupta; Hwee Teoh; Mohammed Al-Omran; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2016-08-26       Impact factor: 3.396

Review 8.  The pulmonary physician in critical care. 13: the pulmonary circulation and right ventricular failure in the ITU.

Authors:  K McNeil; J Dunning; N W Morrell
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

9.  Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways.

Authors:  Jong-Hoon Lim; Jae-Suk Woo; Yung-Woo Shin
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 3.165

10.  Statins as a novel therapeutic strategy in acute lung injury.

Authors:  Sunit Singla; Jeffrey R Jacobson
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.